- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07639333
GRACE - Genetic Insights Into Early pRegnancy Loss Using Cell-free fEtal DNA (GRACE)
GRACE - Genetic Insights Into Early pRegnancy Loss: A Prospective Study Using Cell-free fEtal DNA
The aim of this study is to assess the impact of non-invasive prenatal testing right after an early isolated miscarriage on mental health and on the patient's subsequent care in the year following the miscarriage
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
A blood sample will be added to primary care at the time of diagnosis of early miscarriage to realise non-invasive prenatal testing (NIPT). NIPT will be done on cell-free fetal DNA present in woman's blood to detect potential chromosomal abnormalities. At the 8-week consultation, the results will be shared with the patient if she so wishes. During this appointment, two questionnaires designed to assess her psychological state in relation to the miscarriage (HAD and PGS) will be completed. Depending on the patient's medical history and the results of the NIPT, a tailored care plan may be proposed. At the one-year follow-up appointment, the same questionnaires will be completed and a review will be carried out of the care proposed and provided, as well as the couple's future reproductive plans.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Marie-Laure Gervais
- Telefonnummer: +33 299282555
- E-mail: marie-laure.gervais@chu-rennes.fr
Studiesteder
-
-
-
Rennes, Frankrig
- Rekruttering
- CHU Rennes
-
Kontakt:
- Marion Mercier
- Telefonnummer: +33 299284321
- E-mail: marion.mercier@chu-rennes.fr
-
Ledende efterforsker:
- Marion Mercier, Md
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
-
A stopped pregnancy with an intrauterine pregnancy diagnosed by ultrasound (embryo larger than 7 mm corresponding to a gestational age of 6 weeks and 5 days. This is justified by the fact that fetal fragment (FF) detection is possible at 5 weeks of gestation, or 7 weeks and 5 days)
-
Expulsion of a pregnancy within the last 2 hours
- Patient fluent in French
- Enrolled in a social security program
- Has received oral and written information about the protocol and has signed a consent form to participate in this research.
Exclusion Criteria:
- Diagnosis of an empty gestational sac, ectopic pregnancy, or unknown location
- Ultrasound findings consistent with a molar pregnancy
- Identified cause (preimplantation diagnosis, multiple uterine fibroids or a single fibroid > 5 cm, uterine malformation affecting the uterine cavity, lupus, and antiphospholipid syndrome)
- Inability to obtain a blood sample
- Known current malignant tumor
- Blood transfusions within the last 3 months
- Cell therapy or immunotherapy within the last 3 months
- Previous organ transplant
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Diagnostisk
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Patient
|
cell free fetal DNA analysis |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Psychological distress score
Tidsramme: 8 weeks
|
HADS (Hospital Anxiety and Depression Scale) and PGS (Perinatal Grief Scale) scores. The impact of the NIPT results will be analyzed in relation to these scores, which will be combined into a composite score of psychological distress. HADS questionnaire : Each item is rated on a four-point scale, giving maximum scores of 21 for anxiety and depression. Scores of 11 or more on either subscale are considered to be a significant 'case' of psychological morbidity, while scores of 8-10 represents 'borderline' and 0-7 'normal' The PGS is a self-report questionnaire designed to assess the emotional and psychological impact of perinatal loss, including miscarriage, stillbirth, or neonatal death. The more the score is high, the more the grief is intense. |
8 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Long term Psychological distress score
Tidsramme: 12 months
|
HADS (Hospital Anxiety and Depression Scale) and PGS (Perinatal Grief Scale) at 1 year. The impact of the DPNI results will be analyzed in relation to these scores, which will be combined into a composite score of psychological distress. HADS questionnaire : Each item is rated on a four-point scale, giving maximum scores of 21 for anxiety and depression. Scores of 11 or more on either subscale are considered to be a significant 'case' of psychological morbidity, while scores of 8-10 represents 'borderline' and 0-7 'normal' The PGS is a self-report questionnaire designed to assess the emotional and psychological impact of perinatal loss, including miscarriage, stillbirth, or neonatal death. The more the score is high, the more the grief is intense. |
12 months
|
|
Rate of balanced chromosomal abnormalities in a parent
Tidsramme: 8 weeks
|
Number of parents with a chromosomal rearrangement that explains the occurrence of an early miscarriage |
8 weeks
|
|
Number of modified care pathways
Tidsramme: 12 months
|
Number of modified care pathways based on the patient's etiology and the NIPT results during the year after miscarriages |
12 months
|
|
Number of pregnancies
Tidsramme: 12 months
|
Number of pregnancies and scalability during the year, according to care pathways and NIPT results |
12 months
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Studieleder: Marion Mercier, Md, Rennes University Hospital
- Studiestol: Vincent LAVOUE, Pr, Rennes University Hospital
- Studiestol: Sylvie JAILLARD, Rennes University Hospital
- Studiestol: Erika LAUNAY, Rennes University Hospital
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 35RC25_8835_10_GRACE
- 35RC25_8835_10_GRACE (Andet bevillings-/finansieringsnummer: CHU Rennes)
- 2026-A00248-43 (Anden identifikator: ID-RCB)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
All of the individual participant data collected during the trial will be available, after the primary publication of the results, to any researchers who provide a methodologically sound proposal. Proposals should be directed to dri@chu-rennes.fr. To gain access, data requestors will need to sign a data access agreement; depending on the case, additional formalities may be required.
IPD-delingstidsramme
Data availability after the primary publication of the results and until the database is deleted
IPD-delingsadgangskriterier
Any researchers who provide a methodologically sound proposal will be able to access the IPD ans supporting information. To gain access, data requestors will need to sign a data access agreement; depending on the case, additional formalities may be required.
IPD-deling Understøttende informationstype
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .